Effect of i.v. dipyridamole on cerebral blood flow, blood pressure, plasma adenosine and cAMP levels in rabbits

Journal of the Neurological Sciences

Volumn 148, Issue 2, 1997, Pages 153-161

  Hegedüs, Katalin ^a   Keresztes, Tamás ^a   Fekete, István ^a   Molnár, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Adenosine; Blood pressure; cAMP; Cerebral blood flow; Dipyridamole; Rabbit

Indexed keywords

ADENOSINE; CYCLIC AMP; DIPYRIDAMOLE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; CONTROLLED STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASODILATATION;

ADENOSINE; ANIMALS; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; CYCLIC AMP; DIPYRIDAMOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAVENOUS; MALE; RABBITS; VASODILATOR AGENTS;

EID: 0031589956     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)05352-X     Document Type: Article

References (74)

1. Abebe, W., Makujina, S.R. and Mustafa, S.J. (1994) Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am. J. Physiol., 266: H2018-2025.
2. Aukland, K., Bower, B.F. and Berliner, R.W. (1964) Measurement of local blood flow with hydrogen gas. Circ. Res., 14: 164-187.
3. Beavo, J.A., Reifsnyder and D.H. (1990) Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of the selective inhibitors. Trends Pharmacol. Sci., 11: 150-155.
4. Biaggioni, I. (1992) Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation. Hypertension, 20: 457-465.
5. Boarini, D.J., Kassell, N.F., Olin, J.J. and Sprowell, J.A. (1982) The effect of intravenous dipyridamole on the cerebral and systemic circulation of the dog. Stroke, 13: 842-847.
6. Boeynaems, J.M., Van Coevorden, A. and Demolle, D. (1986) Dipyridamole and vascular prostacyclin production. Biochem. Pharmacol., 35: 2897-2902.
7. 2-release and expression of tissue factor activity by peripheral blood monocytes stimulated with lipopolysaccharide. Thromb. Res., 60: 141-156.
8. Calignano, A., Persico, P., Mancuso, F. and Sorrentino, L. (1992) Adenosine release in morphine-induced hypotension in rats. Gen. Pharmacol., 23: 7-10.
9. Collis, M.G. and Hourani, S.M.O. (1993) Adenosine receptor subtypes. Trends Pharmacol. Sci., 14: 360-366.
10. Conti, J.B., Belardinelli, L., Utterback, D.B. and Curtis, A.B. (1995) Endogenous adenosine is an antiarrhythmic agent. Circulation, 91: 1761-1767.
11. Cusick, J.F. and Myklebust, J. (1980) Continuous quantitative local cerebral blood flow measurement - Calibration of thermal conductivity measurements by the hydrogen clearance method. Stroke, 11: 661-664.
12. 2-receptors in cultured coronary endothelial cells. Naunyn-Schmiedeberg's Arch. Pharmacol., 336: 94-98.
13. Dianzani, C., Brunelleschi, S., Viano, I. and Fantozzi, R. (1994) Adenosine modulation of primed human neutrophils. Eur. J. Pharmacol., 263: 223-226.
14. Dowell, F.J., Hamilton, C.A., McMurray, J. and Reid, J.L. (1993) Effects of a xanthine oxidase/hypoxanthine free radical and reactive oxygen species generating system on endothelial function in New Zealand white rabbit aortic rings. J. Cardiovasc. Pharmacol., 22: 792-797.
15. Edvinsson, L. and Fredholm, B.B. (1983) Characterization of adenosine receptors in isolated cerebral arteries of cat. Br. J. Pharmacol., 80: 631-637.
16. Eigenthaler, M., Nolte, C., Halbrugge, M. and Walter, U. (1992) Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eur. J. Biochem., 205: 471-481.
17. Fehr, T.F., Dickinson, E.S., Goldman, S.J. and Slakey, L.L. (1990) Cyclic AMP efflux is regulated by occupancy of the adenosine receptor in pig aortic smooth muscle cells. J. Biol. Chem., 265: 10974-10980.
18. 2 receptor subtypes. Mol. Pharmacol., 43: 909-914.
19. Gardiner, S.M., Kemp, P.A. and Bennett, T. (1991) Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5′-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br. J. Pharmacol., 103: 1725-1532.
20. Hegedüs, K., Fekete, I. and Molnár, L. (1993) Effects of dipyridamole in spontaneously hypertensive rabbits with diffuse chronic cerebral ischemia. Eur. J. Pharmacol., 237: 293-298.
21. Heistad, D.D., Marcus, M.L., Gourley, J.K. and Busija, D.W. (1981) Effect of adenosine and dipyridamole on cerebral blood flow. Am. J. Physiol., 240: H775-H780.
22. Ibayashi, S., Ngai, A.C., Meno, J.R. and Winn, H.R. (1988) The effects of dipyridamole and theophylline on rat pial vessels during hypocarbia. J. Cereb. Blood Flow Metabol., 8: 829-833.
23. 2 receptor-cAMP system in human aortic endothelial cells. Biochem. Biophys. Res. Commun., 199: 905-910.
24. Jones, C.J., Kuo, L., Davis, M.J., DeFily, D.V. and Chilian, W.M. (1995) Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation, 91: 1807-1813.
25. Kalaria, R.J. and Harik, S.I. (1988) Adenosine receptors and the nucleoside transporter in human brain vasculature. J. Cereb. Blood Flow Metab., 8: 32-39.
26. Kitakaze, M., Hori, M., Takashima, S., Iwai, K., Sato, H., Inoue, M., Kitabatake, A. and Kamada, T. (1992) Superoxide dismutase enhances ischemia-induced reactive hyperemic flow and adenosine release in dogs. A role of 5′-nucleotidase activity. Circ. Res., 71: 558-566.
27. Klabunde, R.E. (1983) Dipyridamole inhibition of adenosine metabolism in human blood. Eur. J. Pharmacol., 93: 21-26.
28. Kobayashi, K., Kuroda, Y. and Yoshioka, M. (1981) Change in cyclic AMP level in synaptosomes from cerebral cortex; increase by adenosine derivates. J. Neurochem., 36: 86-91.
29. Lad, P.M., Nielsen, T.B., Londos, C., Preston, M.S. and Rodbell, M. (1980) Independent mechanisms of adenosine activation and inhibition of the turkey erythrocyte adenylate cyclase system. J. Biol. Chem., 255: 10841-10846.
30. Lerman, B.B. and Engelstein, E.D. (1995) Metabolic determinants of defibrillation. Role of adenosine. Circulation, 91: 838-844.
31. MacGregor, T.R. and Sardi, E.D. (1991) In vitro protein binding behavior of dipyridamole. J. Pharm. Sci., 80: 119-120.
32. Magnusson, A., Halldorsson, H., Thorgeirsson, G. and Kjeld, M. (1994) Endothelin secretion is regulated by cyclic AMP and phosphatase 2A in endothelial cells. J. Cell. Physiol. 161: 429-434.
33. Mahony, C., Wolfram, K.M., Cocchetto, D.M. and Bjornsson, T.D. (1982) Dipyridamole kinetics. Clin. Pharmacol. Ther., 31: 330-338.
34. Maurice, D.H. and Haslam, R.J. (1990) Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol. Pharmacol., 37: 671-681.
35. Meno, J.R., Ngai, A.C. and Winn, H.R. (1993) Changes in pial arteriole diameter and CSF adenosine concentrations during hypoxia. J. Cereb. Blood Flow Metab., 13: 214-220.
36. Moser, G.H., Schrader, J. and Deussen, A. (1989) Turnover of adenosine in plasma of human and dog blood. Am. J. Physiol., 256: C799-806.
37. Muller, T.H., Su, C.A., Weisenberger, H., Brickl, R., Nehmiz, G. and Eisert, W.G. (1990) Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo. Br. J. Clin. Pharmacol. 30: 179-186.
38. Nakane, T. and Chiba, S. (1993) Pharmacological analysis of vasodilation induced by extracellular adenosine 3′,5′-cyclic monophosphate in the isolated and perfused canine coronary artery. J. Pharmacol. Exp. Ther., 264: 1253-1261.
39. Okumura, M., Miura, K., Yamashita, Y., Yukimura, T. and Yamamoto, K. (1992) Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs. J. Pharmacol. Exp. Ther., 260: 1262-1267.
40. Park, T.S., Van Wylen, D.G.L., Rubio, R. and Berne, R.M. (1988) Brain interstitial adenosine and sagittal sinus blood flow during systemic hypotension in piglet. J. Cereb. Blood Flow Metab., 8: 822-828.
41. Peachell, P.T., Lichtenstein, L.M. and Schleimer, R.P. (1991) Differential regulation of human basophil and lung mast cell function by adenosine. J. Pharmacol. Exp. Ther., 256: 717-726.
42. Pearce, W.J., Reynier, A., Lee, J., Aubineau, P., Ignarro, L. and Seylaz, J. (1990) Effects of methylene blue on hypoxic cerebral vasodilation in rabbit. J. Pharmacol. Exp. Ther., 254: 616-625.
43. Pearson, J.D. and Gordon, J.L. (1985) Nucleotide metabolism by endothelium. Annu. Rev. Physiol., 47: 617-627.
44. Phillis, J.W. and Wu, P.H. (1982) The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp. Biochem. Physiol., 72: 179-187.
45. Phillis, J.W. (1989) Adenosine in the control of the cerebral circulation. Cerebrovasc. Brain. Metab. Rev., 1: 26-54.
46. Plagemann, P.G. and Woffendin, C. (1988) Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine. Biochim. Biophys. Acta, 969: 1-8.
47. Prielipp, R.C., Hill, T., Washburn, D. and Zaloga, G.P. (1989) Circulating calcium modulates adrenaline induced cyclic adenosine monophosphate production. Cardiovasc. Res., 23: 838-841.
48. Puiroud, S., Pinard, E. and Seylaz, J. (1988) Dynamic cerebral and systemic circulatory effects of adenosine, theophylline and dipyridamole. Brain Res., 453: 287-298.
49. Rosenberg, P.A., Knowles, R., Knowles, K.P. and Li, Y. (1994) Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J. Neurosci., 14: 2953-2965.
50. Singh, J.P., Rothfuss, K.J., Wiernicki, T.R., Lacefield, W.B., Kurtz, W.L., Brown, R.F., Brune, K.A., Bailey, D. and Dube, G.P. (1994) Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: implications in the treatment of restenosis after angioplasty. J. Am. Coll. Cardiol., 23: 665-671.
51. Sivenius, J., Riekkinen, P.J., Lowenthal, A., Smets, P. and Laakso, M. (1993) Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event. Arch. Neurol., 50: 710-713.
52. Snyder, S.H. (1985) Adenosine as a neuromodulator. Annu. Rev. Neurosci., 8: 103-124.
53. Sobrevia, L., Jarvis, S.M. and Yudilevich, D.L. (1994) Adenosine transport in cultured human umbilical vein endothelial cells is reduced in diabetes. Am. J. Physiol., 267: C39-47.
54. Soderback, U., Sollevi, A. and Fredholm, B.B. (1987) The disappearance of adenosine from blood and platelet suspension in relation to the platelet cyclic AMP content. Acta Physiol. Scand., 129: 189-194.
55. Stange, K., Lagerkranser, M., Rudehill, A. and Sollevi, A. (1989) Effects of adenosine-induced hypotension on cerebral blood flow and metabolism in the pig. Acta Anaesthesiol. Scand., 33: 199-203.
56. Steinhorn, R.H., Morin, F.C., 3rd, Van Wylen, D.G., Gugino, S.F., Giese, E.C. and Russell, J.A. (1994) Endothelium-dependent relaxations to adenosine in juvenile rabbit pulmonary arteries and veins. Am. J. Physiol., 266: H2001-2006.
57. Stella, L., Berrino, L., Maione, S., De Novellis, V. and Rossi, F. (1993) Cardiovascular effects of adenosine and its analogs in anaesthetized rats. Life Sci., 53: 755-763.
58. Stone, T.W. (1981) Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system. Neuroscience, 6: 523-555.
59. Suzuki, S., Sugai, K., Sato, H., Sakatume, M. and Arakawa, D., (1992) Inhibition of active oxygen generation by dipyridamole in human polymorphonuclear leukocytes. Eur. J. Pharmacol., 227: 395-401.
60. Takashima, S., Hori, M., Kitakaze, M., Sato, H., Inoue, M. and Kamada, T. (1993) Superoxide dismutase restores contractile and metabolic dysfunction through augmentation of adenosine release in coronary microembolization. Circulation, 87: 982-995.
61. 1-selective adenosine analogues protects the heart against infarction. Circulation, 85: 659-665.
62. Van Belle, H. (1993) Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Cardiovasc. Res., 27: 68-76.
63. Van Calker, D., Muller, M. and Hamprecht, B. (1979) Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J. Neurochem., 33: 999-1005.
64. 2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br. J. Pharmacol., 109: 424-429.
65. Wesson, D.E. and Elliott, S.J. (1994) Xanthine oxidase inhibits transmembrane signal transduction in vascular endothelial cells. J. Pharmacol. Exp. Ther., 270: 1197-1207.
66. Wu, P.H. and Phillis, J.W. (1982) Uptake of adenosine by isolated rat brain capillaries. J. Neurochem., 38: 687-690.
67. Xiong, Y., Westhead, E.W. and Slakey, L.L. (1995) Role of phosphodiesterase isoenzymes in regulating intracellular cyclic AMP in adenosine-stimulated smooth muscle cells. Biochem. J., 305: 627-633.
68. Yeung, P.K., Mosher, S.J., Macrae, D.A. and Klassen, G.A. (1991) Effect of diltiazem and its metabolites on the uptake of adenosine in blood: an in-vitro investigation. J. Pharm. Pharmacol., 43: 685-689.
69. Yoneyama, Y. and Power, G.G. (1992) Plasma adenosine and cardiovascular responses to dipyridamole in fetal sheep. J. Dev. Physiol., 18: 203-209.
70. Zhang, Y., Geiger, J.D. and Lautt, W.W. (1991a) Improved high-pressure liquid chromatographic-fluorometric assay for measurement of adenosine in plasma. Am. J. Physiol., 260: G658-G664.
71. Zhang, Y. and Lautt, W.W. (1992) Arterial and venous plasma concentrations of adenosine during haemorrhage. Br. J. Pharmacol., 105: 765-767.
72. Zhang, Y., Legare, D.J., Geiger, J.D. and Lautt, W.W. (1991b) Dilazep potentiation of adenosine-mediated superior mesenteric arterial vasodilation. J. Pharmacol. Exp. Ther., 258: 767-771.
73. Zheng, X., Ma, S.J., Zhang, T.H. and Chen, S.C. (1993) Plasma levels of cyclic nucleotides in chronic congestive heart failure and their clinical implication. Int. J. Cardiol., 40: 7-15.
74. Zomerdijk, T.P., Nibbering, P.H., Bezemer, A.C., Lowik, C.W. and Van Furth, R. (1991) A new competition binding assay for determination of the cAMP content of human leukocytes. Biochem. Biophys. Res. Commun., 178: 980-984.